Unspecified Adult Solid Tumor, Protocol Specific [clinicaltrials_resource:5d9da3c7297200edf272bb8c39f0ded9]
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002482]Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [clinicaltrials:NCT00002504]Tumor Cell Vaccine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002505]Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer [clinicaltrials:NCT00002520]Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors [clinicaltrials:NCT00002587]O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors [clinicaltrials:NCT00002604]clinicaltrials:NCT00002663Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors [clinicaltrials:NCT00002677]Biological Therapy in Treating Patients With Metastatic Cancer [clinicaltrials:NCT00002733]Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00002759]Perillyl Alcohol in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002862]Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [clinicaltrials:NCT00002901]Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00002902]Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors [clinicaltrials:NCT00002904]Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma [clinicaltrials:NCT00002909]Penclomedine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00002915]KRN5500 in Treating Patients With Metastatic Solid Tumors [clinicaltrials:NCT00002923]Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer [clinicaltrials:NCT00002939]clinicaltrials:NCT00002943Penclomedine in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00002946]High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002948]Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002950]Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]clinicaltrials:NCT00002994Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors [clinicaltrials:NCT00003004]Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003009]Bizelesin in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003021]MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003028]Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00003038]Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003082]Paclitaxel in Treating Older Patients With Solid Tumors [clinicaltrials:NCT00003092]Dietary Soy Isoflavones for the Prevention of Cancer [clinicaltrials:NCT00003100]Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003108]Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT00003109]Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [clinicaltrials:NCT00003125]Paclitaxel in Treating Women With Recurrent Solid Tumors [clinicaltrials:NCT00003130]Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003132]Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003144]High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT00003173]
condition [clinicaltrials_vocabulary:condition]
Unspecified Adult Solid Tumor, Protocol Specific [clinicaltrials_resource:5d9da3c7297200edf272bb8c39f0ded9]
Bio2RDF identifier
5d9da3c7297200edf272bb8c39f0ded9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5d9da3c7297200edf272bb8c39f0ded9
identifier
clinicaltrials_resource:5d9da3c7297200edf272bb8c39f0ded9
title
Unspecified Adult Solid Tumor, Protocol Specific
@en
label
Unspecified Adult Solid Tumor, ...... da3c7297200edf272bb8c39f0ded9]
@en